3V0V
Fab WN1 222-5 unliganded
Summary for 3V0V
Entry DOI | 10.2210/pdb3v0v/pdb |
Related | 3V0W |
Descriptor | WN1 222-5 Fab (IgG2a) light chain, WN1 222-5 Fab (IgG2a) heavy chain (3 entities in total) |
Functional Keywords | beta sheets, antibody, fab, immune system |
Biological source | Mus musculus More |
Total number of polymer chains | 4 |
Total formula weight | 93616.17 |
Authors | Gomery, K.,Evans, S.V. (deposition date: 2011-12-08, release date: 2012-12-05, Last modification date: 2024-10-16) |
Primary citation | Gomery, K.,Muller-Loennies, S.,Brooks, C.L.,Brade, L.,Kosma, P.,Di Padova, F.,Brade, H.,Evans, S.V. Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS. Proc.Natl.Acad.Sci.USA, 109:20877-20882, 2012 Cited by PubMed Abstract: Escherichia coli infections, a leading cause of septic shock, remain a major threat to human health because of the fatal action to endotoxin (LPS). Therapeutic attempts to neutralize endotoxin currently focus on inhibiting the interaction of the toxic component lipid A with myeloid differentiating factor 2, which forms a trimeric complex together with Toll-like receptor 4 to induce immune cell activation. The 1.73-Å resolution structure of the unique endotoxin-neutralizing protective antibody WN1 222-5 in complex with the core region shows that it recognizes LPS of all E. coli serovars in a manner similar to Toll-like receptor 4, revealing that protection can be achieved by targeting the inner core of LPS and that recognition of lipid A is not required. Such interference with Toll-like receptor complex formation opens new paths for antibody sepsis therapy independent of lipid A antagonists. PubMed: 23184990DOI: 10.1073/pnas.1209253109 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.13 Å) |
Structure validation
Download full validation report
